OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 43 filers reported holding OCUPHIRE PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,248 | -26.6% | 29,328 | -4.9% | 0.00% | – |
| Q2 2023 | $133,881 | +24.8% | 30,848 | +7.8% | 0.00% | – |
| Q1 2023 | $107,303 | -8.3% | 28,614 | -13.7% | 0.00% | – |
| Q4 2022 | $116,988 | +77.3% | 33,141 | +1.7% | 0.00% | – |
| Q3 2022 | $66,000 | -1.5% | 32,603 | -6.0% | 0.00% | – |
| Q2 2022 | $67,000 | -11.8% | 34,666 | +48.6% | 0.00% | – |
| Q1 2022 | $76,000 | -5.0% | 23,325 | +9.4% | 0.00% | – |
| Q4 2021 | $80,000 | -19.2% | 21,325 | +11.3% | 0.00% | – |
| Q3 2021 | $99,000 | +37.5% | 19,160 | +40.3% | 0.00% | – |
| Q2 2021 | $72,000 | +100.0% | 13,660 | +121.9% | 0.00% | – |
| Q1 2021 | $36,000 | +620.0% | 6,156 | +779.4% | 0.00% | – |
| Q4 2020 | $5,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
| Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
| NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
| Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
| MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
| Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
| MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
| Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |